The global bioimpedance analyzers market size is expected to reach USD 1,019.20 million by 2030 according to a new study by Polaris Market Research. The report “Bioimpedance Analyzers Market Share, Size, Trends, Industry Analysis Report, By Product (Multiple-frequency, Single-frequency, and Dual-frequency), By Modality, By Application, By End Use, By Region; Segment Forecast, 2022–2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The industry growth is witnessed by certain factors such as growing incidences of the lifestyle diseases like obesity coupled with rising inclination towards healthy living among the population. In addition, an increasing number of sports rehabilitation centers, fitness clubs, and weight loss clinics also positively influence the industry's development. Moreover, evolving technological advancements and rising investment in the research and developments activities by the leading industry players may accelerate the demand for products across the globe.
Based on the modality, the Wireless Bioimpedance Devices segment is dominating the global industry and is expected to grow at the fastest CAGR in forthcoming years. The increasing number of technological developments for enhancing the proficiencies of the bioimpedance analyzers devices as well as rising investment in the R&D activities by the leading players may attribute to the industry development. The wired segment is likely to grow at a considerable CAGR, owing to the growing incidence of chronic diseases and rising demands for innovative products that may accelerate the segment growth in the near future.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/bioimpedance-analyzer-market/request-for-sample
The emergence of economies such as Brazil, India, and China are likely to drive the market's growth across the globe. Factors such as the growing prevalence of lifestyle diseases, infrastructural developments, and rising awareness regarding obesity and health are attributed to the industry demand. Moreover, increasing initiatives by the government are also supporting the industry growth. For instance, China's State Council had approved the 2016–2020 National Fitness Plan. The motive of that program is to promote sports participation along with encouraging all national fitness levels. Therefore, these factors may act as catalyzing factors for industry growth in the near future.
Major participants such as Omron Corporation, InBody, Bioparhom, Tanita Corporation, Maltron International, Medical Electronics Co., Ltd., Xiaomi, Guangzhou Beautylife Electronic Technology Co., Ltd., RJL Systems, SELVAS Healthcare, Seca GmbH & Co. KG, EVOLT 360, and Bio-Medical Electronics Co., Ltd. are some of the key players operating in the global industry.
There are various market vendors launching their new innovations in the global industry to reinforce their business trade. For instance, in August 2021, Samsung introduced its Galaxy Watch4 Classic- the first smart-watches with the feature OS that is created mutually with Google. Sensors under analyses bio-impedance, optical heart rate beats, and electrical heart.
Polaris Market Research has segmented the bioimpedance analyzers market report on the basis of product, modality, application, end-use, and region:
Bioimpedance Analyzers, Product Outlook (Revenue - USD Million, 2018 – 2030)
Bioimpedance Analyzers, Modality Outlook (Revenue - USD Million, 2018 – 2030)
Bioimpedance Analyzers, Application Outlook (Revenue - USD Million, 2018 – 2030)
Bioimpedance Analyzers, End-Use Outlook (Revenue - USD Million, 2018 – 2030)
Bioimpedance Analyzers, Regional Outlook (Revenue - USD Million, 2018 – 2030)